Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn's disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confocal laser endomicroscopy images from a healthy subject (a) and an Ulcerative Colitis (UC) patient with inactive disease (b). UC patients display increased crypt diameter, intercryptic distance, and perivascular fluorescence. Courtesy of Dr. A. Buda and with permission of Journal of Crohn's and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.](https://figures.cochat.ai/paper-figures/2164d4b5b56e4db78a431b3045efb19f/intestinal-permeability-in-inflammatory-bowel-disease-pathogenesis-clinical-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 5×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 6×
“Both the probes are equally affected by gastrointestinal dilution, motility, bacterial degradation, and renal function; thus, the ratio allows for correcting possible confounding factors [9, 82].”
BackgroundInfluential
Research works printed but not linked: 1
- D'Incà R. Di Leo V. Martines D. Can permeability to sugars predict relapses in Crohn's disease? Gut 1993 34 1, supplement S50 S73
Cited by
Items 501–600 of 759
Guagliano, G., Boeri, L., Merli, M., Yan, H., Vangosa, F. B., Visai, L., Visentin, S., Petrini, P., & Sardelli, L. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101937 · Cited by 7
“These functional aspects can currently be measured using a range of well-established methods [172,173]:”
Almusallam, D., & Alhabardi, S. A. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00891-7 · Cited by 4
“In certain cases, such as in the case of inflammatory bowel disease, there is an apparent increase in the permeability of the otherwise tightly sealed epithelium [20].”
Pathogenic OTUD3 Mutations Predispose to Ulcerative Colitis Due to Barrier Dysfunction
Giri, R., Lee, M., Magor, G. W., Bergot, A., He, Y., Kryza, T., Khan, T., Schreiber, V., Gordon, R. J., Zagani, R., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101659 · Cited by 4
“27,28 Thus, through a translational genetics approach, we have identified OTUD3 as a critical regulator of intestinal barrier function, and demonstrated that its dysregulation is causal in the pathogenesis of UC.”
Ihuţ, A., Răducu, C., Ranta, M., Andrecan, A. F., & Uiuiu, P. (2026) · Microorganisms · doi:10.3390/microorganisms14020447 · Cited by 4
“These mechanisms are directly involved in the pathogenesis of inflammatory bowel disease (IBD) [15,16], coeliac disease [17], and other immunologically based digestive disorders [18].”
Hudson, J., Akhand, A., Nwe, M. T., Coffey, M. J., van Dorst, J. M., Chuang, S., & Ooi, C. Y. (2026) · Journal of Clinical Sleep Medicine · doi:10.1007/s44470-026-00058-y · Cited by 4
Singh, V. K., Almpani, M., & Rahme, L. G. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00233-21 · Cited by 4
“Deregulation of the intestinal barrier integrity is known to be bidirectionally linked to a heightened intestinal inflammatory response (23, 24).”
BackgroundLee, S. H., Hwang, D., Goo, T., & Yun, E. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104539 · Cited by 4
Annunziata, G., Santaniello, M., Cristiano, N., Chieffi, S., Argenziano, G., Ragozzino, G., & Mattera, E. (2024) · Minerva Endocrinology · doi:10.23736/s2724-6507.23.04088-5 · Cited by 6
Reale, M., Costantini, E., Aielli, L., Rienzo, A. D., Biase, G. D., Stefano, A. D., & Cacciatore, I. (2024) · Future Medicinal Chemistry · doi:10.1080/17568919.2024.2351293 · Cited by 4
Vámos, E., Vántus, V. B., Deák, P., Kálmán, N., Sturm, E. M., Nayak, B. B., Makszin, L., Lóránd, T., Gallyas, F., & Radnai, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1558079 · Cited by 5
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_10 · Cited by 4
Donnelly, E. L., Céspedes, N., Hansten, G., Wagers, D., Briggs, A. M., Lowder, C., Schauer, J. D., Haapanen, L. A. D., de Water, J. V., & Luckhart, S. (2022) · ImmunoHorizons · doi:10.4049/immunohorizons.2200057 · Cited by 5
Kennedy, E. C., Ross, F. C., O'Shea, C., Lavelle, A., Ross, R. P., Dempsey, E. M., Stanton, C., & Hawkes, C. P. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-089206 · Cited by 4
Li, J., Rui, X., Xu, L., Liu, Y., Yang, Y., & Yin, D. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115030 · Cited by 4
Kale, P. P., & Pallar, A. (2022) · Current Drug Targets · doi:10.2174/1389450123666220428093419 · Cited by 4
Role of trefoil factors in maintaining gut health in food animals
Fasina, Y. O., Obanla, T. O., Ekunseitan, D. A., Dosu, G., Richardson, J., & Apalowo, O. O. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1434509 · Cited by 4
Spontaneous ileitis and postsurgical murine models of enteric hyperoxaluria
Jaber, K., Zaidan, N., Ho, M. L., Xiong, X., Mishra, R., Nair, A., Mishra, A., Chu, Y., Mokadem, M., & Nazzal, L. (2025) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00043.2025 · Cited by 3
Hao, M., Tang, G., Zhou, E., Fu, R., Wang, M., Jiang, H., Chen, X., Bai, L., Lv, X., & Jin, J. (2025) · Respiratory Research · doi:10.1186/s12931-025-03435-y · Cited by 3
Wee, V. T. K., Shirakawa, H., Yeh, S., & Yeh, C. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109493 · Cited by 3
Wu, G., Li, L., Chen, X.-Y., Zhang, W., Wu, J., Yu, X., & Chen, H. (2024) · Aging · doi:10.18632/aging.205510 · Cited by 3
Intestinal Permeability In Subjects With Rheumatoid Arthritis: A Critical Therapeutic Priority.
Guilliams, T. G., Weintraub, J., & Spar, M. D. (2024) · PubMed Central · Cited by 4
Prebiotic activity of functional whole mushroom powders in short-term in vitro colonic simulations
Daoust, J., Schmalz, J., Meulebroek, L. V., Ghyselinck, J., Verstrepen, L., & Marzorati, M. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106912 · Cited by 3
Zhang, L., Zhu, Z., & Dong, H. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177900 · Cited by 3
IBD Prediction Is Possible, but How Far Are We from Implementing It?
Turpin, W., Kalili, H., Halfvarson, J., & Croitoru, K. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf197 · Cited by 3
Etiopathogenesis of Inflammatory Bowel Diseases
Mrowicki, J., Mrowicka, M., Dziki, A. J., Dziki, Ł. A., & Majsterek, I. (2018) · Biomarkers Journal · doi:10.21767/2472-1646.100046 · Cited by 3
Bioactive compounds of fruit by-products as potential prebiotics
de Albuquerque, M. A. C., de Medeiros, I. U. D., Franco, B. D. G. D. M., Saad, S. M. I., de Leblanc, A. D. M., & LeBlanc, J. (2021) · Valorization of Agri-Food Wastes and By-Products · doi:10.1016/b978-0-12-824044-1.00036-2 · Cited by 4
Utami, T. F. Y., Sahid, M. N. A., Ediati, E., & Sari, I. P. (2023) · JPSCR Journal of Pharmaceutical Science and Clinical Research · doi:10.20961/jpscr.v8i3.71388 · Cited by 3
Rodríguez‐Ibarra, C., Díaz‐Urbina, D., Zagal-Salinas, A. A., Medina‐Reyes, E. I., Déciga‐Alcaraz, A., Hernández‐Pando, R., & Chirino, Y. I. (2024) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2024.127409 · Cited by 3
Fecal proteolytic profiling of pediatric inflammatory bowel disease: A pilot study
Haak, W., Jagt, J. Z., de Meij, T. G. J., Bikker, F. J., Brand, H. S., de Boer, N. K. H., & Kaman, W. E. (2024) · The FASEB Journal · doi:10.1096/fj.202302190r · Cited by 3
“23 In the study of Galipeau et al., an increase in proteolytic activity was detected in adult UC patients prior to clinical diagnosis, which appeared to be associated with alterations in microbiome composition.”
BackgroundZhang, L., Wang, J., Rong, S., & Dong, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123268 · Cited by 3
Gut‐microbiota‐brain Axis and post‐traumatic epilepsy
Mazarati, A. M. (2024) · Epilepsia Open · doi:10.1002/epi4.13113 · Cited by 5
Jiang, X., Sun, Y., Alahmadi, T. A., Manikandan, V., Rengarajan, T., & Zhao, Y. (2022) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101817 · Cited by 3
Osipenko, M. F., Krasner, Y. A., Borodin, I. D., & Kholin, V. D. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-10-49-51 · Cited by 2
“Различные варианты воспалительных заболеваний кишечника (ВЗК) сопровождаются повышенной кишечной проницаемостью и соответственно могут приводить к повышенному поступлению аммиака в систему воротной вены, поэтому закономерен интерес в попытке оценить ассоциацию уровня аммиака сыворотки крови с НАЖБП [7, 8, 9].”
How can the surgeon reduce recurrence after surgery for ileocolic Crohn's disease?
Brown, S. R. (2023) · Seminars in Colon and Rectal Surgery · doi:10.1016/j.scrs.2023.100985 · Cited by 2
Grancieri, M., José, V. P. B. D. S., Toledo, R. C. L., Verediano, T. A., Ana, C. T. S., Lúcio, H. G., de Mejía, E. G., & Martino, H. S. D. (2024) · Food & Function · doi:10.1039/d4fo02199a · Cited by 3
Pinakhina, D. V., Kasyanov, E. D., Rukavishnikov, G. V., Larin, A. K., Veselovsky, V. A., Rakitko, A., Незнанов, Н. Г., Kibitov, A. O., Mazo, G., & Artomov, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1416009 · Cited by 2
Kaarbø, M., Yang, M., Meyer‐Myklestad, M. H., Sundaram, A., de Sousa, M. M. L., Sharma, A., Medhus, A. W., Dyrhol-Riise, A. M., Kvale, D., Hov, J. R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1635523 · Cited by 2
“…mucosal barrier function contributes to incomplete immune recovery in INR aligns with the pathogenic mechanisms observed in IBD, where increased intestinal permeability can lead to translocation of luminal antigens and microorganisms, contributing to intestinal in fl ammation [reviewed in (68)].”
Jian, S., Xin, Z., Xie, Y., Yang, K., Zhang, L., Jian, X., Lin, X., Zhang, L., Han, S., Deng, J., et al. (2025) · eFood · doi:10.1002/efd2.70093 · Cited by 3
Mak, K. M., Ding, S. Y., & Jain, C. L. (2025) · The Anatomical Record · doi:10.1002/ar.70084 · Cited by 5
Wang, F., Xu, S., Wang, Q., Li, X., Jin, Q., Wang, L., Fu, A., & Li, W. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250487 · Cited by 2
Shin, S.-B., Kim, Y., & Park, H. (2025) · Genes & Nutrition · doi:10.1186/s12263-025-00788-3 · Cited by 2
“Disruption of these complexes leads to increased intestinal permeability and luminal antigen translocation, triggering the “leaky gut” phenomenon, a pivotal contributor to the onset and progression of IBD, metabolic diseases, and immune abnormalities [34–36].”
Beul, E. D., Heyse, J., Jurgelewicz, M., Baudot, A., Vu, L. D., & den Abbeele, P. V. (2026) · Nutrients · doi:10.3390/nu18020210 · Cited by 2
“It has been implicated in gastrointestinal disorders (inflammatory bowel disease (IBD) [6], celiac disease [7], and irritable bowel syndrome (IBS) [8]), metabolic conditions (diabetes [9], obesity, and non-alcoholic fatty liver disease [10]), auto-immune diseases (lupus [11], ankylosing spondylitis…”
Mesenterium, a hasi szervként működő visceralis „nagykövet”
Ferencz, A. (2026) · Orvosi Hetilap · doi:10.1556/650.2026.33463 · Cited by 2
Katsouli, O., Lainis, V. G., Goules, A. V., & Vlachoyiannopoulos, P. G. (2026) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.020925.aar · Cited by 2
Wang, P., Li, X., Zhang, J., Wang, J., & Jin, L. H. (2026) · Microbiome · doi:10.1186/s40168-026-02356-2 · Cited by 2
“Disruption of the epithelial barrier increases permeability [74], a hallmark phenotype observed in both IBD patients [74] and Drosophila IBD models [75].”
Du, J., Li, R., Chen, Y., Jing, J., Ren, X., Wang, X., Li, B., Li, K., & Tang, Y. (2026) · Journal of Pain · doi:10.1016/j.jpain.2026.106276 · Cited by 2
Rutgrink, J. M. I., & Velde, A. A. T. (2026) · Immuno · doi:10.3390/immuno6020024 · Cited by 2
“In line with these findings, clinical studies report that elevated permeability can be detected early in CD and is associated with an increased risk of disease relapse [50].”
Abdulla, A. H., Sheikhnoor, A., Ferrao, K., Stiles, L. I., & Mehta, K. J. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02102-w · Cited by 3
“In IBD patients, the integrity of the intestinal mucosal barrier is compromised [72] (Fig.”
Pastras, P., Aggeletopoulou, I., Psalti, V., & Triantos, C. K. (2026) · Pharmaceuticals · doi:10.3390/ph19050783 · Cited by 2
“This triggers an inflammatory cascade, resulting in activation of the intestinal immune system [38].”
Frandeș, S. I., Frandes, O., Macarie, M., Ionele, C. M., & Bataga, S. M. (2026) · Medicina · doi:10.3390/medicina62061160 · Cited by 2
Noninvasive point-of-care measurement of gastrointestinal permeability
Dorshow, R. B., Johnson, J. R., Debreczeny, M. P., Riley, I. R., Shieh, J.-J. J., Rogers, T. E., Hall-Moore, C. M., Shaikh, N., & Tarr, P. I. (2019) · Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications · doi:10.1117/12.2507965 · Cited by 2
Emergence of the Human Gut Microbiota as an Influencer in Health and Disease
Kiernan, M. G., Dunne, S. S., & Dunne, C. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-71963-0_6 · Cited by 2
Mukherjee, A., Tsuchiwata, S., Chang, C., Nicholas, T., Su, C. G., Le, V., Kushner, J., & Kulisek, N. (2022) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1106 · Cited by 2
The potential role of micro- and nanoplastics in the spread of viruses
Andryukov, B. G., Besednova, N. N., Zaporozhets, T. S., Yakovlev, A. A., Matosova, E. V., Kryzhanovsky, S. P., & MIu, S. (2023) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2023-68-1-2-33-44 · Cited by 2
Fu, Y., Waghray, N., Fass, R., & Song, G. (2023) · Diagnostics · doi:10.3390/diagnostics13111901 · Cited by 2
“have been proposed, including disorders of the bidirectional interaction of the brain–gut axis [5,6], increased intestinal permeability [7,8], increased mucosal serotonin levels [9,10], psychological stresses [11–13], enteric nervous system dysfunction [14], and dysbiosis of gut microbiota [2,15].”
BackgroundBlocking the Apelin Receptor (APJ) Attenuates TNBS-Induced Colitis in Rats
Birsen, İ., Sinen, O., Akkan, S. S., Üstünel, İ., & Izgut-Uysal, V. N. (2023) · European Journal of Therapeutics · doi:10.58600/eurjther1883 · Cited by 2
“Intestinal permeability plays a critical role in the development of digestive system diseases such as IBS and IBD [43, 44].”
BackgroundGuo, W., Lv, G., Yang, D., Zhang, W., Li, N., Hu, J., Wu, Y., Pi, Z., & Lin, Z. (2023) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2023.100354 · Cited by 2
Tissue-based in vitro and ex vivo models for intestinal permeability studies
Barros, A. S., & Nunes, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15510-9.00027-x · Cited by 2
Haroun, E., Lim, S. H., & Dutta, D. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_253 · Cited by 2
Brown, B. I. (2019) · Gastrointestinal Disorders · doi:10.3390/gidisord1030027 · Cited by 2
“proteins, improve the integrity of the gut epithelium, and reduce intestinal permeability [141,142].”
BackgroundUkrainets, R. V., & Korneva, Y. S. (2020) · Medicina · doi:10.29234/2308-9113-2020-8-1-20-33 · Cited by 4
Basil, M., Schwartz, D. A., Dalal, R. L., Horst, S., Scoville, E., Adams, D. W., Beaulieu, D. B., Slaughter, J. C., Higginbotham, T., Vaezi, M. F., et al. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06888-5 · Cited by 2
Heckroth, M. A., Eisa, M., & Cave, M. C. (2021) · Cureus · doi:10.7759/cureus.19276 · Cited by 2
“Also, bacterial translocation and endotoxins travel into the portal tract with subsequent activation of inflammatory cells and Kupffer cells, which leads to hepatocellular injury [4,5].”
BackgroundLi, C., Cheng, R., Li, L., Chen, M., & Wu, C. (2022) · BioMed Research International · doi:10.1155/2022/2777882 · Cited by 2
“Intestinal epithelial barrier is important to prevent harmful substances from further damaging the underlying tissues, including bacteria, toxins, and in fl ammatory factors [14, 15].”
Caviglia, G. P., Ribaldone, D. G., & Fagoonee, S. (2023) · Minerva Gastroenterology · doi:10.23736/s2724-5985.22.03215-6 · Cited by 2
Intestinal Alkaline Phosphatase
(2012) · Springer eBooks · doi:10.1007/springerreference_307113 · Cited by 2
Promoting intestinal healing by exclusive enteral nutrition with TGF-β in a mouse model of colitisPreprint
Boumessid, K., Lacroix, V., Ovtchinnikova, E., Quaranta, M., Roy, M., Dumay, A., Thenet, S., Carrière, M., Mas, E., & Barreau, F. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.31.555691 · Cited by 2
“3, 4 Although the causal link(s) between these alterations is not known, a barrier defect of the intestinal mucosa is involved in the genesis and maintenance of this abnormal communication, leading to inflammation and epithelium alterations.(5) In addition, intestinal permeability (IP) is increased, along with an alte…”
BackgroundThe Successful Management Of Ulcerative Colitis With A Nutritional Intervention: A Case Report.
Scheller, B., Winter, C., Zamyad, J., Felmlee, K., & Heard, D. (2019) · PubMed · Cited by 1
Zhang, X., Ma, L., Zhang, C., Hou, B., Zhou, Y., & Yu, S. (2021) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.09.004 · Cited by 1
Ochman, B., Kula, A., & Świętochowska, E. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0038 · Cited by 1
Berthet, L., Casado‐Bedmar, M., & Viennois, É. (2024) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.03.013 · Cited by 1
Cervellati, F., Benedusi, M., Casoni, A., Trinchera, G., Vallese, A., Ferrara, F., Pietrogrande, M. C., & Valacchi, G. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04497-7 · Cited by 1
“…are collected by the macrophages associated with the lungs, transported to the luminal side of the epithelium, and transported to the oropharynx, where they can enter the gastrointestinal tract through the act of swallowing in added to ciliary mucus clearance and directly by ingestion [16, 17].”
Antioxidant effects of selenium-glutathione peroxidase in inflammatory bowel diseases
Fang, Y., Deng, J., Zhang, Y., Yue, S.-Y., Liu, C.-X., Wang, L., Liu, C., & Wang, C. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250463 · Cited by 1
Lee, Y., Yoon, Y., & Choi, K. (2025) · Journal of Oral Microbiology · doi:10.1080/20002297.2025.2473246 · Cited by 1
“A disruption in the barrier of the intestinal epithelial cells may result in increased intestinal permeability, thus increasing exposure to luminal contents and enhanced bacterial translocation, which may then activate immune responses [70,71].”
Martinez, E. E., Philpott, J. D., Lan, J., Hovnanian, K. M. R., & Fasano, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136381 · Cited by 1
Alzubaidi, W. R., Alsehli, M. A., Alhazmi, Y. M., Alnefaie, F. A., Allehaibi, N. S., Alghamdi, A. A., & Mohaini, M. A. (2025) · Journal of Advanced Trends in Medical Research · doi:10.4103/atmr.atmr_76_25 · Cited by 1
Miller, H. E., Sasser, C., Hernandez, M. S., Legako, J. F., Anderson, C. J., Schmitz‐Esser, S., Ericsson, A. C., Broadway, P. R., Sanchez, N. C. B., Carroll, J. A., et al. (2025) · Journal of Animal Science · doi:10.1093/jas/skaf360 · Cited by 1
Tang, F., Luo, Q., Zhang, J., Zhang, M., Liao, Z., Zhou, X., & Liang, X. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151054 · Cited by 1
Trukhan, D. I., & Rozhkova, M. Y. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-244-12-77-87 · Cited by 2
Micro- and Nanoplastics: A Paradigm Shift in the Pathogenesis of Inflammatory Bowel Disease
Saadeh, M., Dutta, P., Hong, G., Oldfield, E. C., & Johnson, D. A. (2026) · Journal of Translational Gastroenterology · doi:10.14218/jtg.2025.00054 · Cited by 2
Wang, Z., Li, N., Zhao, C., Hui, C., Zhao, S., Zheng, Q., Cheng, H., Ding, Y., & Miao, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1703567 · Cited by 1
“Moreover, intestinal mucosal barrier injury may lead to increased intestinal permeability, making it easier for pathogens and harmful substances to enter the blood circulation and trigger systemic inflammatory responses (27).”
Effect of Short-Term Grape Powder Supplementation in Patients with Crohn’s Disease: A Pilot Study
Eftekhar, M. S., Singh, D., Katz, J., Nguyen, V., Menghini, P., Rodriguez‐Palacios, A., Cominelli, F., & Basson, A. R. (2026) · Nutrients · doi:10.3390/nu18121844 · Cited by 1
“The inflammatory bowel disease (IBD) subtype Crohn’s disease (CD) is a chronic, lifelong disorder of the gastrointestinal tract that is characterized by increased intestinal permeability and alterations in fatty acid and SCFA and oxidative stress [1–3].”
Zhang, H., Li, W., Li, Z., Cao, Z., Zhao, X., Hou, M., Zhu, M., & Song, Y. (2026) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2026.117618 · Cited by 1
Montgomery, M. M., Obaidi, M. A. A., Aruleba, R. T., Krassovskaia, P. M., Pacheco, E. A., Franczak, E., Chrest, B. R., Green, T. D., Zeczycki, T. N., McClung, J. M., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-61224-z · Cited by 1
“Chronic colitis has been shown to cause extensive epithelial damage, promote expression of pro-inflammatory cytokines like TNF, and increase epithelial cell turnover 26–29 .”
Mazarati, A. M., Million, M., Larauche, M. H., & Galanopoulou, A. S. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115940 · Cited by 1
Management of Crohn’s Disease in Adult Patients: A Contemporary Surgical Perspective
Delabays, C., Zhu, E., Kefleyesus, A., Perry, W., Ansell, J., Schoepfer, A. M., & Grass, F. (2026) · Biomedicines · doi:10.3390/biomedicines14081774 · Cited by 1
“…creeping fat, which secretes proinflammatory mediators, as well as the chronically inflamed bowel, which presents a defective mucosal barrier and increased intestinal permeability, may decrease exposure to luminal triggers that drive immunological response and intestinal inflammation [6,19].”
Response to the Letter from Drs. Greenstein and Brown
Chandradevan, R., & Kugathasan, S. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy303 · Cited by 1
Krasner, Y. A., Kulygina, Y. A., Valuiskikh, E. Y., & Osipenko, M. F. (2018) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2018-46-5-464-473 · Cited by 1
Vojdani, A. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.01.001 · Cited by 1
Dopamine and Gastrointestinal Mucosa Function
Feng, X., Xue, H., Guo, Z., Yan, J., Liu, S., & Zhu, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6586-5_4 · Cited by 1
SUBSTITUTOS DE SACAROSE EM CHOCOLATES: UMA REVISÃO
Costa, D., & Lannes, S. C. D. S. (2022) · doi:10.22533/at.ed.4702229064 · Cited by 2
Establishing the cut-offs of leaky gut syndrome diagnostic: where are we now?
Rodina, J., & Derovs, A. (2022) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2022-0089 · Cited by 2
“Compared to the control group, IBD patients had a significantly higher Cs /Cf ratio for SCFAs, including acetic, valeric, isocaproic, caproic and propionic acids.”
BackgroundInfluentialLeaky gut – terapêutica e tratamento da síndrome do intestino permeável: uma revisão bibliográfica
Nascimento, H. H. S., de Oliveira, V. H. L., dos Reis, E. B. B., Souza, D. M., & Ferreira, M. B. (2022) · Research Society and Development · doi:10.33448/rsd-v11i16.38739 · Cited by 1
Jun, Y. K., Lee, S. W., Kim, K. W., Moon, J. M., Koh, S., Lee, H. J., Kim, J. S., Han, K., & Im, J. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220770 · Cited by 1
The Usefulness of Tissue Calprotectin in Pediatric Crohn’s Disease—A Pilot Study
Szymańska, E., Szymańska, S., Karkucińska‐Więckowska, A., Wierzbicka, A., Kierkuś, J., & Dądalski, M. (2023) · Gastrointestinal Disorders · doi:10.3390/gidisord5010003 · Cited by 1
“Crohn’s disease (CD) is a chronic gastro-intestinal condition with impaired immunological background [1].”
BackgroundKulygina, Y. A., Осипенко, М. Ф., Skalinskaya, M. I., & Pal'chunova, K. D. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh201789215-19 · Cited by 1
F-actin dynamics couples sphingolipid metabolism to epithelial barrier integrity in chronic colitisPreprint
Medvedeva, S. S., Popova, J. V., Achasova, K. M., Kulygina, J., Nickelwart, E. A., Suldina, L. A., Morozova, K. N., Osipenko, M. F., & Kozhevnikova, E. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.21.700747 · Cited by 1
Chee, M. E. (2016) · The Atrium (University of Guelph)
Infektionsutlöst autoimmunitet vid ME/CFS. En förklaringsmodell
Blomberg, J. (2016) · Socialmedicinsk tidskrift · doi:10.62607/smt.v93i4.42323
Metadata
- Authors
- Michielan, A., & D’Incà, R.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Michielan, Andrea
- ORCID
- Michielan, Andrea
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- Pages
- 628157-628157
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4637104
- OpenAlex
- W2176502392
- Cited by
- 709
- References
- 146
- Citations by year
- 2026: 61 · 2025: 54 · 2024: 86 · 2023: 91 · 2022: 99 · 2021: 82 · 2020: 81 · 2019: 58 · 2018: 38 · 2017: 37 · 2016: 21
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Oxford
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, leaky gut, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mucosal barrier dysfunction, gut microbiota, mucus layer, paracellular permeability, adhesion molecules, confocal laser endomicroscopy, butyrate, zinc, probiotics, intestinal inflammation
- MeSH terms
- Humans, Intestinal Mucosa, Permeability, Tumor Necrosis Factor-alpha, Zinc, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.